Medicare Enrolled

Dr. Kostas Botsoglou, M.D.

Internal Medicine · Cheektowaga, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
2475 HARLEM RD, Cheektowaga, NY 14225
8779911889
In practice since 2008 (17 years)
NPI: 1295981652 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Botsoglou from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Botsoglou? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Botsoglou

Dr. Kostas Botsoglou is an internal medicine specialist in Cheektowaga, NY, with 17 years of NPI registration. Based on federal Medicare data, Dr. Botsoglou performed 342 Medicare services across 174 unique beneficiaries.

Between the years covered by Open Payments, Dr. Botsoglou received a total of $2,416,317 from 54 pharmaceutical and/or device companies across 4419 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Botsoglou is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ 342 Medicare services $2,416,317 industry payments

Medicare Practice Summary

Medicare Utilization ↗
342
Medicare services
Bottom 36% in NY for internal medicine
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
174
Unique beneficiaries
$101
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~20 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
291 $92 $150
New patient office visit, complex (60-74 min) 29 $168 $280
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
22 $128 $215
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,416,317
Total received (2018-2024)
Avg $345,188/year across 7 years
Top 0% in NY for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
54
Companies
4,419
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,326,899 (96.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$75,754 (3.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,664 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$472,791
2023
$403,390
2022
$375,209
2021
$287,743
2020
$230,229
2019
$346,827
2018
$300,127

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$161,384
Mallinckrodt Hospital Products Inc.
$100,145
Janssen Biotech, Inc.
$48,059
UCB, Inc.
$36,178
Amgen Inc.
$31,715
AstraZeneca Pharmaceuticals LP
$27,734
GENZYME CORPORATION
$27,329
Kyowa Kirin, Inc.
$19,031
Boehringer Ingelheim Pharmaceuticals, Inc.
$17,051
ANI Pharmaceuticals, Inc.
$1,840
Novartis Pharmaceuticals Corporation
$427
PFIZER INC.
$354
E.R. Squibb & Sons, L.L.C.
$309
GlaxoSmithKline, LLC.
$238
Sandoz Inc.
$202
Alexion Pharmaceuticals, Inc.
$189
Janssen Scientific Affairs, LLC
$143
Madrigal Pharmaceuticals
$112
SANOFI-AVENTIS U.S. LLC
$89
Organon Llc
$72
SCILEX PHARMACEUTICALS INC.
$67
Actelion Pharmaceuticals US, Inc.
$41
Lilly USA, LLC
$37
Kiniksa Pharmaceuticals International, plc
$29
Octapharma USA, Inc.
$17
Top 3 companies account for 65.5% of 2024 payments
All-time payments by company (2018-2024) ›
Mallinckrodt Hospital Products Inc.
$560,530
Amgen Inc.
$326,355
ABBVIE INC.
$236,575
AbbVie Inc.
$178,942
Celgene Corporation
$167,239
GENZYME CORPORATION
$152,177
Janssen Biotech, Inc.
$115,366
AstraZeneca Pharmaceuticals LP
$113,598
Novartis Pharmaceuticals Corporation
$113,180
UCB, Inc.
$87,811
Mallinckrodt Enterprises LLC
$72,880
Janssen Scientific Affairs, LLC
$49,931
Aurinia Pharma U.S., Inc.
$31,597
AbbVie, Inc.
$30,876
Mallinckrodt LLC
$29,376
Horizon Therapeutics plc
$26,171
PFIZER INC.
$25,973
Boehringer Ingelheim Pharmaceuticals, Inc.
$20,914
Kyowa Kirin, Inc.
$19,257
ANI Pharmaceuticals, Inc.
$15,198
Ironwood Pharmaceuticals, Inc
$13,800
Regeneron Healthcare Solutions, Inc.
$6,836
Lilly USA, LLC
$5,692
Exeltis, USA Inc.
$4,776
Flexion Therapeutics, Inc.
$3,825
Alexion Pharmaceuticals, Inc.
$1,411
E.R. Squibb & Sons, L.L.C.
$1,299
GlaxoSmithKline, LLC.
$886
SANOFI-AVENTIS U.S. LLC
$820
Takeda Pharmaceuticals U.S.A., Inc.
$462
Genentech USA, Inc.
$429
Genentech, Inc.
$411
Sandoz Inc.
$375
Johnson & Johnson Health Care Systems Inc.
$279
Horizon Pharma plc
$199
MEDAC PHARMA, INC.
$137
Madrigal Pharmaceuticals
$112
Organon LLC
$97
Janssen Pharmaceuticals, Inc
$73
Organon Llc
$72
SCILEX PHARMACEUTICALS INC.
$67
Actelion Pharmaceuticals US, Inc.
$65
Novo Nordisk Inc
$29
Kiniksa Pharmaceuticals International, plc
$29
Ferring Pharmaceuticals Inc.
$28
Oxford Immunotec USA Inc
$24
Avion Pharmaceuticals
$21
Celltrion USA Inc.
$20
Antares Pharma, Inc.
$20
Sunovion Pharmaceuticals Inc.
$18
Octapharma USA, Inc.
$17
Daiichi Sankyo Inc.
$15
Bio Products Laboratory USA, Inc.
$14
Sobi, Inc
$13
Top 3 companies account for 46.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · BREO · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUEXIS · DUZALLO · EUFLEXXA · EVENITY · Enbrel · FORTEO · GLOPERBA · Gammaplex · Gloperba · HADLIMA · HUMIRA · HYRIMOZ · Humira · INFLECTRA · INJECTAFER · INVOKANA · KEVZARA · KRYSTEXXA · Kineret · LOKELMA · LUMIZYME · LUPKYNIS · NO PRODUCT DISCUSSED · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · Otezla · Otrexup · Ozempic · PENNSAID · POMPE - DISEASE · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · REZDIFFRA · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SOLIRIS · STELARA · STRENSIQ · Sotyktu · Strensiq · TALTZ · TAVNEOS · TEPEZZA · TRELEGY ELLIPTA · TREMFYA · TSPOT TB TEST · Tavneos · ULTOMIRIS · UPTRAVI · UTIBRON · Uloric · Ultomiris · VIMOVO · Victoza · XARELTO · XELJANZ · YUFLYMA · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (96%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for internal medicine in NY.

Looking for an internal medicine specialist in Cheektowaga?
Compare internal medicine physicians in the Cheektowaga area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
531
Per 100K population
55.9
County median income
$71,175
Nearest hospital
UPSTATE NEW YORK VA HEALTHCARE SYSTEM (WESTERN NY VA HEALTHCARE SYSTEM)
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Botsoglou is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 0% of NY peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Botsoglou experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Botsoglou performed 291 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Botsoglou receive payments from pharmaceutical companies?
Yes. Dr. Botsoglou received a total of $2,416,317 from 54 companies across 4,419 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Botsoglou's costs compare to other internal medicine physicians in Cheektowaga?
Dr. Botsoglou's average Medicare payment per service is $101. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Botsoglou) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →